Cancer in Asia: Analysis of the Lung Cancer Therapeutics Market


USD 1,000.00

* Required Fields

USD 1,000.00


Be the first to review this product

Table of Contents

PharmAsia Global Market Study 2000: Cancer in Asia: Analysis of The Lung Cancer Therapeutics MarketOverview and ScopeOverview and ScopeMarket Engineering Analysis of the Lung Cancer Therapeutics Market in Asia (1997-2007)Market DefinitionsMarket Engineering Research Measurement SystemChallenges Facing the Lung Cancer Therapeutics Market in AsiaMarket Engineering Valuation and Revenue Forecasts (1997-2007)Competitive StructureMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsDevelop Dedicated Field Force Specifically for Anti-Cancer DrugsProvision of Data Management Support to DoctorsOffer Patient Counseling SupportOpen Cancer Hospitals or Tie-Up with Cancer Research InstitutesPersuade Local Entrepreneurs to Venture into Research and DevelopmentConduct Awareness Programs for Early Cancer DetectionFollow Governments’ Policies and Adjust Products and Related Parameters in a Timely MannerDevelop New Products Having Good Curative Properties and Low Side EffectsStrengthen Promotions among Doctors; Pharmacies and Patients

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.